We have revised our Privacy Policy that is in effect as of May 25, 2018. Please click here to access it.
Search
Contact Us
Careers
External Funding
News and Media
about us
corporate timeline
Professor Yoram Palti founded Novocure in 2000. We have since accomplished many significant milestones.
leadership
Meet our leaders, who have extensive experience across oncology, biotechnology and medical device industries.
corporate presentation
We pioneer a profoundly different approach to treating cancer called Tumor Treating Fields.
ESG report
Corporate social responsibility is important to us, and patients remain at the heart of the work we do every day.
our therapy
our pipeline
clinical trials
Our mechanism of action is broadly applicable across a variety of solid tumors.
novocuretrial.com
The science of Tumor Treating Fields extends beyond glioblastoma. Novocure has ongoing or completed clinical trials investigating Tumor Treating Fields in mesothelioma, brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer and liver cancer.
patient-forward
news and media
press releases
press kits
media gallery
featured stories
investor relations
press releases
corporate presentation
events
annual reports
sec filings
stock information
corporate governance
faq
email alerts
NASDAQ: current stock price
179.27
6.23
last update
5/14/2021 16:00pm
careers
our locations
current job listings
Amended Statement of Ownership
May 10, 2021
Amended Statement of Ownership
February 16, 2021
Amended Statement of Ownership
February 10, 2021
Amended Statement of Ownership
February 08, 2021
Amended Statement of Ownership
February 01, 2021
Amended Statement of Ownership
January 14, 2021
Amended Statement of Ownership
July 10, 2020
Amended Statement of Ownership
February 12, 2020
Amended Statement of Ownership
February 11, 2020
Amended Statement of Ownership
February 07, 2020
1
2
»
Archive
[-]
2021
April
February
January
[+]
2020
December
November
October
September
August
July
June
May
April
March
February
January
[+]
2019
December
November
October
September
August
July
June
May
April
March
February
January
[+]
2018
December
November
October
September
August
July
June
May
April
March
February
January
[+]
2017
December
November
October
September
August
July
June
May
April
March
February
January
[+]
2016
December
November
October
September
August
July
June
May
April
March
February
January
[+]
2015
December
November
October
September
August
July
May
April
March
February
January
[+]
2014
December
November
October
September
August
July
June
May
April
February
January
[+]
2013
December
November
August
July
May
January
[+]
2012
November
August
May
January
[+]
2011
December
November
October
August
April
March
[+]
2010
October
June
[+]
2009
September
[+]
2008
November
April
[+]
2007
March
about us
corporate timeline
Professor Yoram Palti founded Novocure in 2000. We have since accomplished many significant milestones.
leadership
Meet our leaders, who have extensive experience across oncology, biotechnology and medical device industries.
corporate presentation
We pioneer a profoundly different approach to treating cancer called Tumor Treating Fields.
ESG report
Corporate social responsibility is important to us, and patients remain at the heart of the work we do every day.
our therapy
our pipeline
clinical trials
Our mechanism of action is broadly applicable across a variety of solid tumors.
novocuretrial.com
The science of Tumor Treating Fields extends beyond glioblastoma. Novocure has ongoing or completed clinical trials investigating Tumor Treating Fields in mesothelioma, brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer and liver cancer.
patient-forward
news and media
press releases
press kits
media gallery
featured stories
investor relations
press releases
corporate presentation
events
annual reports
sec filings
stock information
corporate governance
faq
email alerts
careers
our locations
current job listings
